In head and neck cancer cells, decreased DKK1 expression was associated with acquired cisplatin resistance [42], whereas overexpression of DKK1 in a glioma cell line sensitized these cells to DNA damaging agents including cisplatin [54]. This evidence concerns the gene DKK1 and head and neck cancer.